Simultaneous recording of hippocampal oxygen and glucose in real time using

constant potential amperometry in the freely-moving rat by Kealy, John et al.
B
S
c
J
D
h





a
A
R
R
A
K
S
B
M
A
D
A
1
d
o
F
1
F
a
2
0
h
Journal of Neuroscience Methods 215 (2013) 110– 120
Contents lists available at SciVerse ScienceDirect
Journal  of  Neuroscience  Methods
journa l h omepa g e: www.elsev ier .com/ locate / jneumeth
asic  Neuroscience
imultaneous  recording  of  hippocampal  oxygen  and  glucose  in  real  time  using
onstant  potential  amperometry  in  the  freely-moving  rat
ohn  Kealy ∗,  Rachel  Bennett,  John  P.  Lowry
epartment of Chemistry, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland
 i g  h  l  i  g  h  t  s
We show  that average  concentrations  of hippocampal  oxygen  and  glucose  are  100.26  ±  5.76 M and 0.60 ± 0.06  mM  respectively.
We  show  that there  are  uncoupled  changes  in  oxygen  and  glucose  during  neuronal  activation.
Anaesthesia and  carbonic  anhydrase  inhibition  both  significantly  increase  hippocampal  oxygen.
Anaesthesia,  dimethyl  sulfoxide  administration  and carbonic  anhydrase  inhibition  significantly  increase  hippocampal  glucose.
We  show  that changes  in hippocampal  metabolism  can  be detected  in real  time  using  constant  potential  amperometry.
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a  b  s  t  r  a  c  t
Amperometric  sensors  for  oxygen  and  glucose  allow  for real time  recording  from  the  brain  in freely-
moving  animals.  These  sensors  have  been  used  to  detect  activity-  and  drug-induced  changes  in
metabolism  in  a number  of brain  regions  but little  attention  has  been  given  over  to  the  hippocampus
despite  its  importance  in  cognition  and  disease.  Sensors  for  oxygen  and  glucose  were  co-implanted
into  the  hippocampus  and  allowed  to record  for several  days.  Baseline  recordings  show  that  basal  con-
centrations  of  hippocampal  oxygen  and  glucose  are  100.26  ± 5.76  M and  0.60  ± 0.06  mM  respectively.
Furthermore,  stress-induced  changes  in  neural  activity  have  been  shown  to  significantly  alter  concen-
trations  of  both  analytes  in  the hippocampus.  Administration  of O2 gas  to the animals’  snouts  results  in
significant  increases  in hippocampal  oxygen  and  glucose  and  administration  of N2 gas  results  in a signifi-imethyl sulfoxide
cetazolamide
cant  decrease  in  hippocampal  oxygen.  Chloral  hydrate-induced  anaesthesia  causes  a significant  increase
in hippocampal  oxygen  whereas  treatment  with  the  carbonic  anhydrase  inhibitor  acetazolamide  signifi-
cantly  increases  hippocampal  oxygen  and  glucose.  These  findings  provide  real time electrochemical  data
for the  hippocampus  which  has been  previously  impossible  with  traditional  methods  such  as  micro-
dialysis  or  ex vivo  analysis.  As  such,  these  sensors  provide  a window  into  hippocampal  function  which
can  be  used  in  conjunction  with  behavioural  and pharmacological  interventions  to further  elucidate  the
s  of afunctions  and  mechanism
. Introduction
Using implantable sensors allows for stable, long-term recor-
ing of a number of common analytes in the extracellular fluid (ECF)
f the brain including oxygen (Lowry et al., 1996, 1997; Lowry and
illenz, 2001; Bolger and Lowry, 2005), glucose (Hu and Wilson,
997; Fillenz and Lowry, 1998a; Lowry et al., 1998a,b,c; Lowry and
illenz, 2001; Dixon et al., 2002), nitric oxide (Brown et al., 2009)
nd glutamate (Kulagina et al., 1999; McMahon et al., 2006a, 2006b,
007; Qin et al., 2008; Tian et al., 2009). Unlike other methods
∗ Corresponding author. Tel.: +353 1 474 7165.
E-mail address: John.Kealy@nuim.ie (J. Kealy).
165-0270/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
ttp://dx.doi.org/10.1016/j.jneumeth.2013.02.016ction  of the hippocampus  in  normal  and  disease  states.
© 2013 Elsevier B.V. All rights reserved.
such as microdialysis, electrochemical sensors are small, can record
at a sub-second temporal resolution and cause less disruption in
surrounding tissue compared to microdialysis guide cannulae and
probes (Bungay et al., 2003; Borland et al., 2005). While limited in
terms of what analytes can be measured at any one time, the high
specificity and temporal resolution of sensors make them ideal for
measuring the relationships between neurochemistry, metabolism
and neural activity (Lowry and O’Neill, 2006).
Tissue levels of oxygen in the brain have been traditionally
measured indirectly by jugular bulb oximetry (Andrews et al.,
1991; Feldman and Robertson, 1997; De Deyne et al., 1998) or
by using functional magnetic resonance imaging (fMRI) to moni-
tor the blood-oxygen-level dependent (BOLD) signal (Ogawa et al.,
1990; Menon et al., 1992; Glover, 2011). Oxygen can also be mea-
sured more directly by voltammetry using Clark-type electrodes
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mplanted into the brain tissue (Clark et al., 1958; Krolicki and
eniger-Follert, 1980; Doppenberg et al., 1998; Gupta et al., 1999).
lassical Clark electrodes are restrictive due to their large size; they
ave poor spatial resolution for measuring specific brain regions
nd are too bulky to be used reliably in freely-moving animals.
ore recently, these restrictions have been overcome by the devel-
pment of sensors utilising constant potential amperometry (CPA)
hat can measure tissue oxygen levels from specific brain regions
Bolger et al., 2011a).  Carbon paste electrodes (CPEs) have been
hown to detect oxygen with high sensitivity and selectivity at a
ub-second temporal resolution (Bolger et al., 2011b). Changes in
issue oxygen levels measured by CPEs are related to changes in
egional cerebral blood flow (Lowry et al., 1997) and these changes
re directly comparable to the BOLD signal from fMRI studies
Lowry et al., 2010; Francois et al., 2012). As such, tissue oxygen lev-
ls measured using CPEs can be used to assess neural activity from
ocalised regions of the brain in freely-moving animals (Li et al.,
011; Russell et al., 2012).
Similarly, measuring tissue levels of glucose in the brain has
raditionally relied on a number of indirect and direct tech-
iques. While non-invasive measurements of brain glucose using
RI  technology is possible (Choi et al., 2001), its use is not as
idespread as the use of the BOLD signal in fMRI. Direct samp-
ing of cerebral spinal fluid using microdialysis allows for local
CF levels of glucose to be determined (Sandberg et al., 1986)
nd for activity-related changes in glucose concentrations to be
ssessed (Fellows et al., 1992; McNay et al., 2000, 2001; De
undel et al., 2009). Microdialysis is limited by its poor tempo-
al resolution with most collection methods limited to the range
f minutes, though higher temporal resolution is possible with
ecent advances in dialysate collection and analysis (Morales-
illagrán et al., 2008; 2012). However, the real time data acquisition
ade possible by glucose biosensors allow for the kind of anal-
sis that is not currently possible using microdialysis (Lowry
t al., 1998a,b,c). A number of different glucose biosensors have
een developed and have been shown to be able to rapidly
etect changes in cerebral glucose (Boutelle et al., 1986; Shram
t al., 1997). Measuring glucose in real time with CPA can be
chieved using platinum/poly(o-phenylenediamine)/glucose oxi-
ase (Pt/PPD/GOx) biosensors (Lowry et al., 1994, 1998b; Dixon
t al., 2002).
Sensors have been previously used to show the varied metabolic
haracteristics of different parts of the brain including the striatum
Lowry et al., 1998b; Bazzu et al., 2009; Brown et al., 2009; Calia
t al., 2009), nucleus accumbens (Finnerty et al., 2012; Francois
t al., 2012), motor cortex (Lowry et al., 2010), prefrontal cortex
Finnerty et al., 2012) and whisker barrel cortex (Li et al., 2011).
owever, there has been less attention has been afforded to the
ippocampus (Freund et al., 1989; Hu and Wilson, 1997) despite
ts pivotal roles in declarative memory (Scoville and Milner, 1957;
ohen et al., 1999; Eacott and Easton, 2011), spatial navigation
O’Keefe and Nadel, 1978; Morris et al., 1982; D’Hooge and De
eyn, 2001) and its links to various neurodegenerative/psychiatric
isorders (Heckers and Konradi, 2010; Marlatt and Lucassen,
010; Bast, 2011; Dhikav and Anand, 2011; Bonilha et al., 2012).
herefore, there is a need for sensor data recorded in real-time to
upplement the large amount of electrophysiological data (Bliss
nd Lomo, 1973; Martin et al., 2000; Morris et al., 2003; Colgin and
oser, 2010), microdialysis data (McNay et al., 2001; Gold, 2003;
e Bundel et al., 2009; López-Pérez et al., 2012) and molecular
ata from tissue samples (Gooney et al., 2002; Minichiello, 2009;
arry and Commins, 2011) already published from work in the
ippocampus. Some behavioural work with hippocampal sensors
as been performed; it has been recently shown that oxygen
ensors can be used to differentiate between the activity of the
orsal and ventral regions of the hippocampus in a spatial memory Methods 215 (2013) 110– 120 111
task (McHugh et al., 2011). Yet, there has been little work done
using sensors to measure basal levels of oxygen and glucose in
the hippocampus or to determine how basic behavioural and
pharmacological interventions can alter levels of these particular
analytes.
Hence, in this paper, we describe a number of experiments
where tissue levels of hippocampal oxygen and glucose are simul-
taneously measured in the rat using CPEs and Pt/PPD/GOx sensors
respectively. Alterations in hippocampal oxygen and glucose levels
are detected during behavioural-induced changes in neural activ-
ity using the tail pinch and restraint stress paradigms and during
periods of mild hyperoxia and hypoxia. Levels of hippocampal
oxygen and glucose are also monitored following treatment with
saline, the anaesthetic chloral hydrate, the commonly-used vehicle
dimethyl sulfoxide and the carbonic anhydrase inhibitor acetazo-
lamide (Diamox®).
2. Materials and methods
2.1. Subjects
Male Sprague Dawley rats (250–300 g; Charles River Labora-
tories International, Inc.; U.K.) were housed in a temperature-
controlled facility with a 12 h light/dark cycle (lights on at
07:00) with access ad libitum to food and water. All procedures
were performed under license in accordance with the Euro-
pean Communities Regulations 2002 (Irish Statutory Instrument
566/2002).
2.2. Data acquisition and statistical analysis
All electrochemical experiments were performed using a low
noise potentiostat (Biostat IV, ACM Instruments, Cumbria, U.K.).
Data acquisition was  performed using a PowerLab® interface sys-
tem (ADInstruments Ltd., Oxford, U.K.) and a Logiq laptop or Mac.
The software packages used were LabChart for Windows and Mac
(Version 6) and EChem for Windows Version 1.5.2 (ADInstruments
Ltd., Oxford, U.K.).
All data was preliminarily processed in Microsoft® Excel® for
Mac  2011 (Version 14.2.2) before being exported to GraphPad
Prism® 5 for Mac  OS X (Version 5.0a) for statistical analysis and
plotting of graphs. Data was either normalised to baseline levels
for ease of comparison or area under curve (AUC) analysis was  per-
formed to quantify any observed changes in the sensor signals for
statistical analysis. For multiple comparisons, repeated-measures
and mixed-factorial analysis of variance tests (ANOVAs) with Bon-
ferroni post hoc analysis were used as appropriate. Paired t-tests
were also when comparing results from two  different time points.
p < 0.05 was  considered to be significant and all data is presented
as the mean ± standard error of the mean (SEM).
2.3. Working electrode preparation and surgery
Carbon paste (O’Neill et al., 1982) was prepared by thor-
oughly mixing 0.71 g of graphite powder (1–2 m,  Aldrich) with
250 l of silicone oil (high temperature, Aldrich). CPEs were
made from Teflon®-coated silver wire (8 T, 200 m bare diame-
ter, 256 m coated diameter; Advent Research Materials, Suffolk,
U.K.) as reported previously (Lowry et al., 1997). Pt/PPD/GOx sen-
sors were made by immobilising GOx (from Aspergillus niger; EC
1.1.3.4, type VII-S; Sigma) in a poly(o-phenylenediamine) (PPD)
film by potentiometric electropolymerisation of the monomer
o-phenylenediamine (Sigma; 300 mmol/l; Geise et al., 1991) on
the bare disc end of a freshly cut Teflon®-coated platinum wire
(5 T, 125 m bare diameter, 175 m coated diameter; Advent
Research Materials, Suffolk, U.K.). A deoxygenated solution of
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he o-phenylenediamine monomer (300 mmol/l) was prepared in
0 ml  phosphate buffered saline (PBS; pH 7.4; 0.15 M NaCl, 0.04 M
aH2PO4 and 0.04 M NaOH; all from Sigma). An aliquot of 5 ml
f this solution was then added to a weighed quantity of GOx
5 mg/ml) and electropolymerised using CPA at +700 mV  versus a
aturated calomel electrode as previously described (Lowry et al.,
994).
Experiments to determine the sensitivity and selectivity for
hese sensor designs have previously been performed. CPEs are sen-
itive to changes in oxygen concentration and selective for oxygen
ver a range of interferent species (Bolger et al., 2011a,b). Simi-
arly, the Pt/PPD/GOx biosensor is sensitive to changes in glucose
oncentration and is selective for glucose over a range of interfer-
nt species (Lowry and O’Neill, 1994; Lowry et al., 1994; 1998b).
n vitro calibrations were performed using CPA in a standard three-
lectrode glass electrochemical cell containing 20 ml  PBS at room
emperature. A saturated calomel electrode was used as the refer-
nce electrode and a bare platinum wire served as the auxiliary
lectrode. The applied potential for CPEs was -650 mV  versus a
aturated calomel electrode and for Pt/PPD/GOx electrodes was
700 mV  versus a saturated calomel electrode. For CPE O2 calibra-
ions (0–1200 M)  the PBS solution was vigorously purged with
2-free N2 (BOC Ireland, average O2 content 2 ppm, maximum O2
ontent 5 ppm) for at least 30 min  to attain adequate deaeration of
he PBS solution before recording. An O2 concentration of 240 M
as obtained by bubbling atmospheric air using an air pump (RENA,
.S.A.) through the PBS for a minimum of 30 min  (Bourdillon et al.,
982; Foster et al., 1993). Finally an O2 concentration of 1200 M
as obtained by bubbling pure O2 gas (BOC Ireland) through the
BS for a minimum of 30 min  (Bourdillon et al., 1982; Bazzu et al.,
009). For Pt/PPD/GOx glucose calibrations (0–100 mM)  aliquots of
 1 M glucose stock solution were injected into the PBS solution in
he cell. The PBS was briefly stirred using a magnetic stirring bead to
niformly mix  the solution. Additionally, ascorbic acid calibrations
0–1000 M)  were performed in the same manner to confirm that
here was minimal interference from ascorbic acid in vivo. The cur-
ent was recorded throughout the course of each experiment and
nalysis was performed using quiescent steady-state conditions.
For sensor implantation, animals were anaesthetised using
soflurane (4% in air for induction, 1.5–3.0% for maintenance;
soFlo®, Abbott, U.K.) and placed in a stereotaxic frame. The skull
as exposed and four anchor screws were implanted into the skull
one anchor screw doubling as the auxiliary electrode) and burr
oles were made for the reference electrode and the working elec-
rodes (see Section 2.3). The Pt/PPD/GOx sensor was  implanted into
he hippocampus (−5.6 mm from Bregma, +4.6 mm from midline,
.1 mm from dorsal surface of brain; co-ordinates adapted from De
undel et al., 2009). The CPE was implanted into the hippocam-
us in the same hemisphere 1.0 mm anterior to the Pt/PPD/GOx
ensor. The sensors were cemented into place using dental cement
Dentalon® Plus, Heraeus-Kulzer, Germany) and the gold connec-
ors at the end of each electrode were inserted into a six-pin Teflon®
ocket (Plastics One, U.S.A.) which was also cemented in place. All
nimals were given saline (0.9%) and analgesia (Buprecare, Animal-
are Ltd., U.K.) and allowed to recover in an incubator.
.4. Experimental procedure
24 h following recovery, animals were singly housed in Raturn®
ampling cage systems (BASi, U.S.A.) in a temperature-controlled
acility with a 12 h light/dark cycle (lights on at 07:00) with access
d libitum to food and water. All experiments were performed in
he animal’s home bowl. The implanted sensors from each animal
ere connected to the potentiostat via the six-pin Teflon® socket
sing a flexible screened six core cable (Plastics One, U.S.A.). Cabling Methods 215 (2013) 110– 120
was mounted through a swivel on the Raturn® bowl to allow free
movement of the animal in the bowl.
Neuronal activation was achieved using the tail pinch stress
paradigm (Antelman et al., 1975; Boutelle et al., 1990) and the
restraint stress paradigm (Cloutier et al., 2009). In the tail pinch
stress paradigm (5 min), a small clip is placed on the animal’s tail,
which induces gnawing behaviour in the animal for the period of
the tail pinch. The animal is allowed to gnaw on a piece of wood
and, in turn, this gnawing induces neuronal activation which will
cause metabolic changes in the brain that can be detected using the
sensors (Bolger and Lowry, 2005). In the restraint stress paradigm
(5 min), the animal is held immobile manually and any physi-
cal attempts to free itself are associated with neuronal activation
which can be detected using the sensors in a similar manner to the
tail pinch stress paradigm.
Mild hyperoxic and hypoxic conditions were produced by the
administration of O2/air and N2/air mixtures respectively in order
to verify the response of the CPEs to changes in tissue levels of
oxygen (Bolger and Lowry, 2005). Each gas was delivered to the
animal’s snout (3 min; keeping a distance of approximately 2–3 cm
from the snout) from a gas cylinder (BOC, see Section 2.4) via plastic
tubing. A flow rate of approximately 150 ml/min was used.
All injections were administered intraperitoneally (i.p.) on sep-
arate days in the following order: (1) saline (0.9%; NaCl from Sigma;
n = 6); (2) chloral hydrate (350 mg/kg in 0.9% saline; Sigma; n = 8);
(3) dimethyl sulfoxide (DMSO; 33% in 0.9% saline; Sigma; n = 6);
and (4) acetazolamide (Diamox®; 50 mg/kg in 33% DMSO; Sigma;
n = 6). Animals were weighed on each day and the respective doses
for each animal were prepared immediately prior to injection.
3. Results
3.1. Basal concentrations of oxygen and glucose in the
hippocampus
Caution needs to be applied when using in vitro electrode cal-
ibration data to estimate in vivo concentrations. This is primarily
because of the differences between a free solution and a tissue
matrix; factors such as capacitance current, diffusion, sensitivity,
etc. need to be considered. However, it can be useful to deter-
mine approximate concentration data and with this in mind two
time points were selected from each rat (n = 10) on the second
day of recording (one in the day, one in the night) in order to
determine extracellular concentrations for comparisons with pre-
viously reported work. The second day was chosen to allow time
for sensors to settle and so that baseline levels were determined
prior to any experimental interventions. The baseline current val-
ues were matched to the post-implantation calibration data for
the CPE (average sensitivity to oxygen = −1.07 nA/M)  and the
pre-implantation calibration data for Pt/PPD/GOx (average sen-
sitivity to glucose = 1.56 nA/mM)  as post-implantation calibration
data is not available for Pt/PPD/GOx as the GOx component is lost
during the explant procedure (Lowry et al., 1998c). It was deter-
mined that the basal oxygen concentration in the hippocampus is
100.26 ± 5.76 M during the day and 99.37 ± 5.51 M during the
night. It was determined that the basal glucose concentration in the
hippocampus is 0.60 ± 0.06 mM during the day and 0.57 ± 0.07 mM
during the night. Paired t-tests revealed no significant differences
between day and night for hippocampal oxygen (t = 0.3361; df = 9;
p > 0.05) or for glucose (t = 1.700; df = 9; p > 0.05). However, it must
be noted that hippocampal oxygen levels fluctuate based on activity
(McHugh et al., 2011) so it is difficult to determine a true basal con-
centration. In the case of both oxygen and glucose, these values are
given only as a guide and as such, the data in the following sections
are expressed in either unconverted units (i.e. current changes; nA)
or as a percentage of baseline levels (i.e. normalised data; %).
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.2. Effect of neuronal activation on hippocampal levels of oxygen
nd glucose
Neuronal activation was induced using two  different stress
aradigms. Each stress paradigm was split into three time periods.
he baseline period was taken as the 5 min  prior to the beginning
f the test, the stress period covered the 5 min  of the actual test
pplication and post-baseline period covered the 5 min  following
he end of the test. The data was split into 30 s time bins and all data
ere expressed as a percentage of baseline levels for comparison
Fig. 1(a) and (b)). AUC analysis was performed on the raw data to
etermine the mean change from the baseline signal during each
f the stress paradigms (expressed in nA. min).
The tail pinch stress paradigm involved a clip being placed on the
nimal’s tail and allowing the animal to gnaw on a piece of wood.
he gnawing rather than the pressure of the clip induces global
euronal activation with an associated increase in regional cerebral
lood flow, resulting in an increase in hippocampal levels of oxygen
nd glucose (n = 14 administrations in 5 animals; Fig. 1(a)). Paired
-tests on the data analysed via AUC showed that hippocampal
ig. 1. Effect of neuronal activation on hippocampal oxygen and glucose: (a) shows the a
uring  a 5 min  period of mild stress (tail pinch; grey box) with all data normalised to ba
or  hippocampal oxygen (CPE) and glucose (Pt/PPD/GOx) respectively. There were signific
b)  shows the average changes in hippocampal oxygen (closed circles) and glucose (ope
ormalised to baseline levels, (d) and (f) show the changes in area under the curve (AU
here  was  a significant difference in AUC between baseline and restraint conditions for th Methods 215 (2013) 110– 120 113
oxygen significantly increased by 28.83 nA. min (t = 2.827; df = 13;
p < 0.05; Fig. 1(c)) and that hippocampal glucose also significantly
increased at a rate of 0.1145 nA. min  (t = 3.023; df = 13; p < 0.01;
Fig. 1(e)) during the tail pinch compared to baseline levels. Both
analytes followed a similar time course following the tail pinch with
hippocampal oxygen and glucose returning to baseline levels after
17.20 ± 2.59 min  and 17.98 ± 2.56 min  respectively.
The restraint stress paradigm involved manually holding the
animal in place, restricting its movement. Periods of struggle are
associated with an increase in neuronal activation with an associ-
ated increase in regional cerebral blood flow. As in the tail pinch
stress paradigm, restraint stress resulted in an increase in hip-
pocampal levels of oxygen and glucose (n = 13 administrations in
5 animals; Fig. 1(b)). Paired t-tests on the data analysed via AUC
showed that while hippocampal oxygen significantly increased at
a rate of 32.13 nA. min  (t = 2558; df = 12; p < 0.05; Fig. 1(d)), the
observed change in hippocampal glucose did not reach significance
(t = 1.274; df = 12; p > 0.05; Fig. 1(f)) during the restraint period
compared to baseline levels. Both analytes followed a similar time
course following the period of restraint with hippocampal oxygen
verage changes in hippocampal oxygen (closed circles) and glucose (open squares)
seline levels, (c) and (e) show the changes in area under the curve (AUC; nA. min)
ant differences in AUC between baseline and tail pinch conditions for both sensors,
n squares) during a 5 min  period of mild stress (restraint; grey box) with all data
C; nA. min) for hippocampal oxygen (CPE) and glucose (Pt/PPD/GOx) respectively.
e CPE alone. *p < 0.05; **p < 0.01.
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nd glucose returning to baseline levels after 13.42 ± 1.97 min  and
4.33 ± 2.43 min  respectively.
.3. Effect of mild hyperoxia and mild hypoxia on hippocampal
evels of oxygen and glucose
Animals were administered with O2 or N2 gas in order to induce
hort periods of mild hyperoxia or mild hypoxia respectively. This
as performed in order to verify the response of the CPEs to changes
n tissue levels of oxygen (Bolger and Lowry, 2005). The baseline
eriod was taken as the 3 min  prior to the beginning of the test, the
as administration period covered the 3 min  of the actual test appli-
ation (mild hyperoxia/hypoxia) and post-baseline period covered
he 3 min  following the end of the test. The data was split into 30 s
ime bins and all data were expressed as a percentage of baseline
evels. AUC analysis was performed to determine the mean change
rom the baseline signal during each of the gas administrations
expressed in nA. hour).
ig. 2. Effect of gas administrations on hippocampal oxygen and glucose: (a) shows the a
uring  a 3 min period of mild hyperoxia (grey box) with all data normalised to baselin
ippocampal oxygen (CPE) and glucose (Pt/PPD/GOx) respectively. There were significan
b)  shows the average changes in hippocampal oxygen (closed circles) and glucose (open 
o  baseline levels, (d) and (f) show the changes in AUC (nA. min) for hippocampal oxygen
UC  between baseline and hypoxic conditions for the CPE alone. *p < 0.05; ***p < 0.001. Methods 215 (2013) 110– 120
Administration of O2 gas to the animals’ snouts resulted in mild
hyperoxia associated with an increase in hippocampal oxygen lev-
els (n = 26 administrations in 9 animals; Fig. 2(a)). Paired t-tests on
the data analysed via AUC showed that hippocampal oxygen sig-
nificantly increased by 67.37 nA. min (t = 4.353; df = 25; p < 0.001;
Fig. 2(c)) and that hippocampal glucose also significantly increased
at a rate of 0.023 nA. min  (t = 2.637; df = 25; p < 0.05; Fig. 2(e)) during
administration of O2 gas compared to baseline levels. Both ana-
lytes followed a similar time course following the end of the O2 gas
administration with hippocampal oxygen and glucose returning to
baseline levels after 11.10 ± 1.35 min  and 7.01 ± 1.25 min respec-
tively.
Administration of N2 gas to the animals’ snouts resulted in mild
hypoxia associated with a decrease in hippocampal oxygen levels
(n = 23 administrations in 9 animals; Fig. 2(b)). Paired t-tests on
the data analysed via AUC showed that hippocampal oxygen sig-
nificantly decreased by 77.20 nA. min  (t = 9.628; df = 22; p < 0.001;
Fig. 2(d)) but that there was  no significant change in hippocampal
glucose during the N2 gas administration (t = 2.035; df = 22; p > 0.05;
verage changes in hippocampal oxygen (closed circles) and glucose (open squares)
e levels, (c) and (e) show the changes in area under the curve (AUC; nA. min) for
t differences in AUC between baseline and hyperoxic conditions for both sensors,
squares) during a 3 min  period of mild hypoxia (grey box) with all data normalised
 (CPE) and glucose (Pt/PPD/GOx) respectively. There was a significant difference in
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ig. 2(f)) compared to baseline levels. Following the end of the N2
as administration, hippocampal oxygen levels returned to base-
ine levels after 8.09 ± 1.18 min.
Taken together, these results verify that CPEs respond rapidly
o changes in hippocampal oxygen in response to different concen-
rations of inhaled oxygen.
.4. Effect of drug treatments on hippocampal levels of oxygen
nd glucose
Animals were administered with a number of different drug
reatments in order to determine the effects of saline (0.9%), chlo-
al hydrate (350 mg/kg in saline), dimethyl sulfoxide (DMSO; 33%
n saline) and acetazolamide (Diamox®; 50 mg/kg in 33% DMSO) on
ippocampal metabolism. All treatments were given via i.p. injec-
ion. The baseline period was taken as the hour prior to the injection
nd data was  collected for 10 h following the injection. The data
as split into 10 min  time bins and all data were expressed as
 percentage of baseline levels for visualisation and comparison.
UC analysis was performed to determine the mean change from
he baseline signal during each of the drug treatment conditions
expressed in nA. hour).
Saline treatment showed no significant long-term changes in
ippocampal metabolism (n = 6; Fig. 3(a)). A repeated-measures
NOVA on the normalised data did not reveal any significant
ffect for saline treatment on hippocampal oxygen when com-
ared to baseline (F = 1.153; df = 10; 50; p > 0.05). Similarly, there
as no significant effect for saline treatment on hippocampal glu-
ose (F = 1.371; df = 10; 50; p > 0.05). However, there was  a transient
ncrease in hippocampal metabolism due to the injection stress.
 paired t-test on the AUC-analysed data revealed a significant
ig. 3. Effect of drug administrations on hippocampal oxygen (closed circles) and glucose
ime  = 0 h. All data expressed as a percentage of pre-injection baseline levels: (a) saline (
350  mg/kg in 0.9% saline): There were significant increases in oxygen in the first 3 hours
33%  in saline): there was  a significant increase in glucose from hour 3 onwards, (d) acet
he  first 5 h and from hours 4–8 there was a significant increase in glucose. Methods 215 (2013) 110– 120 115
increase of 20.64 nA. hour in hippocampal oxygen following the
injection compared to baseline levels (t = 3.220; df = 5; p < 0.05) in
the first 5 min  post-injection. However, there was no such effect for
injection stress on hippocampal glucose (t = 1.856; df = 5; p > 0.05).
The three drug treatments all affected hippocampal metabolism
when observed over several hours. The anaesthetic chloral hydrate
caused significant changes in hippocampal metabolism (n = 8;
Fig. 3(b)). A repeated-measures ANOVA on the normalised data
revealed that chloral hydrate treatment had a significant effect
on hippocampal oxygen when compared to baseline (F = 12.98;
df = 10; 70; p < 0.001) and a 2 × 11 mixed factorial ANOVA with
treatment (saline; chloral hydrate) as a between subject variable
and time (baseline and hours 1–10 post-injection) as a within
subject variable on the normalised data showed that there was
no overall significant effect for treatment when compared to
the saline-treated group (F = 3.539; df = 1, 120; p > 0.05). However,
there was a significant effect for time (F = 9.661; df = 10, 120;
p < 0.001) and a significant interaction effect (F = 7.121; df = 10, 120;
p < 0.001). Compared to saline injections at the same time points
(i.e. 0–3 h post-injection), an unpaired t-test on the AUC-analysed
data revealed that there was  a significant increase in hippocampal
oxygen of 65.36 ± 18.33 nA. hour compared to baseline (t = 3.565;
df = 13; p < 0.01; Fig. 4(a)).
A repeated-measures ANOVA on the normalised data revealed
that chloral hydrate treatment had a significant effect on hip-
pocampal glucose when compared to baseline (F = 4.696; df = 10;
70; p < 0.001) and a 2 × 11 mixed factorial ANOVA with treatment
(saline; chloral hydrate) as a between subject variable and time
(baseline and hours 1–10 post-injection) as a within subject vari-
able on the normalised data showed that there was  a significant
effect for treatment (F = 4.894; df = 1, 120; p < 0.05), a significant
 (open squares). All drug administrations were i.p. and are marked by an arrow at
0.9%): There were no long-term changes in oxygen or glucose, (b) chloral hydrate
 while glucose significantly increased over the course of the recordings, (c) DMSO
azolamide (50 mg/kg in 33% DMSO): there were significant increases in oxygen in
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Fig. 4. Effect of drug administrations on hippocampal oxygen (CPE) and glucose (Pt/PPD/GOx): (a) and (c) show the changes in area under the curve (AUC; nA. hour) for
hippocampal oxygen (CPE) and glucose (Pt/PPD/GOx) respectively following a chloral hydrated injection. There was a significant increase in AUC for hippocampal oxygen
between saline and chloral hydrate during the first 3 h post-injection, (b) and (d) show the changes in area under the curve (AUC; nA. hour) for hippocampal oxygen (CPE) and
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lucose (Pt/PPD/GOx) respectively following DMSO and acetazolamide injections. T
reatment and both DMSO and saline treatment during the first 3 h post-injection.
cetazolamide treatment and saline treatment. **p < 0.01; ***p < 0.001.
ffect for time (F = 2.964; df = 10, 120; p < 0.01) and a significant
nteraction effect (F = 3.512; df = 10, 120; p < 0.001). An unpaired
-test on the AUC-analysed data revealed that there was  a non-
ignificant increase of 1.12 ± 0.68 nA. hour in hippocampal glucose
0–10 h post-injection) compared to baseline (t = 1.801; df = 11;
 > 0.05; Fig. 4(c)).
As acetazolamide does not dissolve easily in saline, a 33% solu-
ion of DMSO was  used as a vehicle. Animals were treated with 33%
MSO in order to act as a control for acetazolamide treatment. It
as found that DMSO alone had a significant effect on hippocampal
etabolism (n = 6; Fig. 3(c)). While a repeated-measures ANOVA on
he normalised data revealed that DMSO treatment had a signifi-
ant effect on hippocampal oxygen (F = 2.124; df = 10; 50; p < 0.05)
nd on hippocampal glucose (F = 5.330; df = 10; 50; p < 0.001) when
ompared to baseline. Acetazolamide treatment was  also shown
o have a significant effect on hippocampal metabolism (n = 6;
ig. 3(d)). A repeated-measures ANOVA on the normalised data
evealed that acetazolamide treatment had a significant effect on
ippocampal oxygen (F = 7.626; df = 10; 50; p < 0.001) and on hip-
ocampal glucose (F = 4.698; df = 10; 50; p < 0.001) when compared
o baseline.
Comparing the effects of saline-, DMSO- and acetazolamide-
reated animals on hippocampal oxygen, a 3 × 11 mixed factorial
NOVA with treatment (saline; DMSO; acetazolamide) as a
etween subject variable and time (baseline and hours 1–10 post-
njection) as a within subject variable on the normalised data
howed that there was a significant effect for treatment (F = 11.82;
f = 2, 15; p < 0.001), time (F = 7.90; df = 10, 150; p < 0.001) as well as
n interaction effect (F = 3.69; df = 20, 150; p < 0.001). Compared to
aline injections at the same time points (i.e. 0–3 h post-injection),
 one-way ANOVA on the AUC-analysed data showed that there
as a significant effect for drug treatment on hippocampal oxygenwas a significant increase in AUC for hippocampal oxygen between acetazolamide
ionally, there was a significant increase in AUC for hippocampal glucose between
(F = 36.46; df = 2, 16; p < 0.001; Fig. 4(b)). Bonferroni post hoc analy-
sis revealed that while there was  no significant difference between
saline- and DMSO-treated animals (p > 0.05), acetazolamide did
have a significant effect on hippocampal oxygen. Acetazo-
lamide treatment significantly increase hippocampal oxygen by
61.80 nA. hour compared to saline-treated animals (p < 0.001) and
by 54.71 nA. hour compared to DMSO-treated animals (p < 0.001).
Comparing the effects of saline-, DMSO- and acetazolamide-
treated animals on hippocampal glucose, a 3 × 11 mixed factorial
ANOVA on the normalised data showed that there was a signifi-
cant effect for treatment (F = 3.75; df = 2, 15; p < 0.05), time (F = 6.05;
df = 10, 150; p < 0.001) as well as an interaction effect (F = 3.00;
df = 20, 150; p < 0.001). Compared to saline injections, a one-way
ANOVA on the AUC-analysed data showed that there was a signif-
icant effect for drug treatment on hippocampal glucose (F = 6.679;
df = 2; 14; p < 0.01; Fig. 4(d)). Bonferroni post hoc analysis revealed
that while there was no significant difference between saline-
and DMSO-treated animals (p > 0.05), acetazolamide did have a
significant effect on hippocampal glucose. Acetazolamide treat-
ment significantly increase hippocampal glucose by 0.840 nA. hour
compared to saline-treated animals (p < 0.001) but there was  no
significant difference between acetazolamide- and DMSO-treated
animals (p > 0.05).
4. Discussion
While CPEs have been previously used to measure hippocampal
oxygen during various behavioural tasks (McHugh et al., 2011),
this is the first full characterisation of hippocampal metabolism to
be published using these sensors. Additionally, by co-implanting a
CPE and Pt/PPD/GOx biosensor in the same region of the hippocam-
pus, we have also been able to demonstrate that the temporal
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elationships between hippocampal oxygen and glucose levels vary
uring a number of different conditions. Here, we  demonstrate
hat neuronal activation (increased during stress paradigms and
ecreased during anaesthesia) can alter levels of hippocampal oxy-
en and glucose. Furthermore, pharmacological interventions can
e monitored for hours using these sensors on a subsecond scale.
There have been few studies utilising sensors to measure
ippocampal glucose as most research groups tend to employ
icrodialysis. Most studies report much higher concentrations
f glucose in the hippocampus compared to the value reported
bove (0.60 ± 0.06 mM);  one study using a glucose biosensor puts
he concentration as high as 2.6 ± 0.2 mM in anaesthetised rats
Hu and Wilson, 1997). However, a number of studies utilising
icrodialysis in freely-moving rats have suggested that the basal
ippocampal glucose concentration is somewhere between 1 and
.5 mM;  1.00 ± 0.06 mM (McNay and Gold, 1999), 1.2 ± 0.03 mM
McNay et al., 2000), 1.05 ± 0.02 mM (McNay and Sherwin, 2004b),
.49 ± 0.05 mM (Rex et al., 2009) and 1.36 ± 0.04 mM (de Bundel
t al., 2009) all being representative examples of such findings.
Moreover, these microdialysis studies utilise a zero net flux
odel of measuring glucose and there has been criticism of the
se of this method to determine basal concentrations of analytes in
he brain due to variability in the perfusate being used by different
roups (McNay and Sherwin, 2004a)  and the trauma caused by the
mplantation of the microdialysis probe (Chen, 2003, 2005a, 2005b,
006). These criticisms are reinforced by the disparity observed
etween sensor recordings and microdialysis analysis due to the
rauma caused by the much larger microdialysis probe (Khan and
ichael, 2003). It has been reported that dopamine microsensors
mplanted directly adjacent to microdialysis probes are unable to
etect the release of dopamine whereas microsensors implanted
 mm away from the probe are unaffected (Yang et al., 1998). Fur-
hermore, our more modest estimate of 0.60 ± 0.06 mM may  also be
rtificially lower than actual concentrations as it has been shown
hat enzyme-based sensors have a tendency to lose 20–50% sen-
itivity when implanted into the brain (Hu et al., 1994). Taken
ogether, we predict that the basal glucose concentration in the
ippocampus is somewhere between our estimate and those of the
icrodialysis studies referenced above.
While previous work in the hippocampus has reported changes
n oxygen concentration, we believe this is the first report to deter-
ine the in vivo basal concentration of hippocampal oxygen in the
reely-moving rat. In comparison, the oxygen levels found in the
ippocampus (100.26 ± 5.76 M)  in this study are quite high with
ippocampal oxygen being 33.6 mm Hg (∼52.8 M)  in the anaes-
hetised gerbil (Nair et al., 1987) and 20.3 mm Hg (∼31.9 M)  in the
naesthetised rat (Cater et al., 1961). Compared to other regions in
he rat brain, the hippocampal oxygen levels found here also appear
o be higher with 50 M in the caudate nucleus (Zimmerman and
ightman, 1991) and 37 ± 16 M (Bazzu et al., 2009) or 33 ± 14 M
Calia et al., 2009) in the striatum.
However, our estimates of the basal concentration of oxygen
n the hippocampus are given only as a guide as basal concentra-
ions of any measure of neural activity are difficult to establish.
irstly, it is hard to objectively determine what constitutes a base-
ine level of activity when considering the normal functions of a
pecific brain region. Secondly, overall changes in regional cerebral
lood flow could impact on the oxygen levels even when a brain
egion of interest is “inactive”. Oxygen levels fluctuate consider-
bly even across short time scales with locomotor activity being an
bvious influence on hippocampal oxygen even when not engaged
n a hippocampus-dependent task (McHugh et al., 2011). As it has
reviously been shown that oxygen measured using amperometric
ensors is directly comparable to the BOLD signal in fMRI (Lowry
t al., 2010; Francois et al., 2012), these fluctuations may  also be
ue to changes in synaptic activity in a given region of the brain Methods 215 (2013) 110– 120 117
(Logothetis et al., 2001; Goense and Logothetis, 2008; Li et al., 2011).
Therefore, these concentrations are given only as preliminary esti-
mates and the main findings of these experiments are expressed
as changes away from the baseline rather than absolute changes
in concentration as we would expect the direction and extent of
these changes to be similar to those found with other sampling
methods.
Using CPEs with CPA in the striatum, the tail pinch stress
paradigm is associated with an increase in oxygen levels, which
returns to baseline after the removal of the tail clip (Lowry and
Fillenz, 1997). This increase and return to baseline in the striatum
has been replicated using CPEs with differential pulse amperome-
try (Bolger and Lowry, 2005) and a graphite-based conical oxygen
sensor with CPA (Bazzu et al., 2009). Lowry and Fillenz (1997) also
found that there was  a decrease in striatal glucose measured using
a Pt/PPD/GOx biosensor during the tail pinch and that following
the removal of the tail clip, glucose levels increased higher than
baseline levels. This effect of the tail pinch on striatal glucose has
also been found using microdialysis (Fray et al., 1996). While we
found that both hippocampal oxygen and glucose levels changed
in response to the tail pinch stress paradigm, our data did not mir-
ror the findings in the striatum as we observed an overshoot in
hippocampal oxygen after the removal of the clip whereas glucose
rapidly returned to baseline (the opposite to the striatum). As hip-
pocampal oxygen increased immediately after removal of the tail
clip, this indicates that during the tail pinch oxygen supply was
approximately balanced with utilisation. On the other hand, hip-
pocampal glucose did increase significantly during the tail pinch
but rapidly returned to baseline following the removal of the tail
clip. So although there is increased supply of oxygen in the stri-
atum during the tail pinch, there is not increased utilisation of
oxygen, thus leading to an overall increase in the oxygen concen-
tration in the striatum. In contrast, it appears there is an increase
in supply of hippocampal oxygen with a concurrent increase in its
utilisation during the tail pinch paradigm. Evidence for this comes
from the finding that when the tail clip is removed, the utilisation
of hippocampal oxygen decreases (as neuronal activation should
decrease) but supply remains high for several minutes following
the test, perhaps reflecting an increase in regional cerebral blood
flow due to increased activity by the animal in the bowl following
the removal of the tail clip. This increase may  be due to increased
locomotor activity which has been shown previously to be closely
correlated to increases in the hippocampal oxygen signal (McHugh
et al., 2011).
In the case of hippocampal glucose, there seems to be an increase
in its supply but not its utilisation (as tissue levels increased dur-
ing neuronal activation), reflecting an alternative use for glucose
during this form of neuronal activation compared to the situation
in the striatum. Differences in how tail pinch stress affects the stri-
atum and the hippocampus are not to be unexpected as neuronal
activation from tail pinch stress has been shown to increase striatal
dopamine and ascorbic acid compared with 5-hydroxytryptamine
and 5-hydroxyindole acetic acid in the hippocampus (Boutelle et al.,
1990), perhaps reflecting different mechanisms and different roles
for the two regions.
The effect of acetazolamide on oxygen levels has been previ-
ously demonstrated in the striatum using CPEs with differential
pulse amperometry (Dixon et al., 2002; Bolger and Lowry, 2005)
and a graphite-based conical oxygen sensor (Bazzu et al., 2009)
where administration of acetazolamide results in increased striatal
oxygen levels lasting for several hours. Bolger and Lowry (2005)
also demonstrated that the increase in striatal oxygen was corre-
lated with regional cerebral blood flow. Here, we  found a similar
effect for acetazolamide on hippocampal oxygen; administration
of acetazolamide causes a rapid increase in hippocampal oxygen
lasting for several hours.
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However, due to the difficulty in forming an acetazolamide solu-
ion in saline we used a high concentration of DMSO in order to
dminister the drug. Analysis on the normalised data suggests that
MSO treatment resulted in a significant increase in hippocam-
al glucose levels beginning about 3 h after the injection and this
esult was also found following acetazolamide treatment. As aceta-
olamide treatment in the absence of DMSO is not associated with
ny changes in striatal glucose (Dixon et al., 2002), this suggests
hat in this study that acetazolamide treatment itself has no effect
n hippocampal glucose but the DMSO used as the vehicle does.
t the very least, there may  be an interaction between the DMSO
nd acetazolamide as the AUC analysis showed that acetazolamide
reatment significantly increase hippocampal glucose levels. The
ffects of DMSO on brain metabolism has been implied for sev-
ral years; early work indicated that the application of DMSO to
rain slices increases glucose consumption (Ghosh et al., 1976)
nd in vitro administration of DMSO appears to cause more var-
ed dose-dependent effects on glucose metabolism in brain slices
rom guinea pigs (Nasrallah et al., 2008). Comparing our results
o those of these other groups creates a complex picture with
ow concentrations of DMSO administered directly to brain tis-
ue causing rapid changes in glucose metabolism in contrast to
ur findings where high concentrations of DMSO administered
ntraperitoneally caused a delayed but long-lasting increase in
lucose concentration, perhaps reflecting a decrease in glucose con-
umption over longer time periods.
The suppression of neural activity by anaesthesia and its effects
n glucose in the brain has been previously demonstrated using a
umber of different anaesthetic agents, including chloral hydrate
Fellows et al., 1992; Fillenz and Lowry, 1998b; Lowry et al., 1998a;
owry and Fillenz, 2001; Uematsu et al., 2009; Horn and Klein,
010). Our data for hippocampal oxygen follows the same pat-
erns observed in the striatum during chloral hydrate anaesthesia,
amely an increase in tissue levels of oxygen during the period of
naesthesia with a return to baseline levels following the return to
onsciousness (Bolger and Lowry, 2005). This increase in oxygen is
ssociated with a decrease in neuronal activation and an increase in
egional cerebral blood flow (Lowry et al., 1998a; Lowry and Fillenz,
001). The anaesthesia-induced increase in hippocampal glucose
bserved here in the normalised data analysis is in agreement with
icrodialysis data from the hippocampus (Horn and Klein, 2010)
nd the striatum (Fellows et al., 1992), radioactive tracing experi-
ents in the cortex (McDougal et al., 1990) and glucose biosensors
n the cortex (Netchiporouk et al., 2001). However, this change in
ippocampal glucose was not reflected in the AUC analysis. Bear-
ng in mind that conflicting results have also been reported using
lectrochemical detection methods in the striatum where chloral
ydrate administration has been associated with a decrease in tis-
ue glucose (Fillenz and Lowry, 1998b; Lowry and Fillenz, 2001).
et, it would be expected that a decrease in neuronal activity should
esult in an increase in tissue glucose due to decreased utilisation.
upport for this comes from the growing body of evidence to sug-
est that the brain switches between glucose and lactate under
ifferent levels of activity (Dienel and Hertz, 2001). The utilisation
f glucose by the brain has been suggested to be dependent on neu-
onal activity (Serres et al., 2005) and it has been shown that there is
ncreased utilisation of lactate during chloral hydrate anaesthesia,
uggesting that the brain switches to lactate as an energy source
uring this (Yamada et al., 2009) and other anaesthetic conditions
Serres et al., 2004; Horn and Klein, 2010).
The use of these sensors is not restricted to acute pharmaco-
ogical studies; CPEs have been used to show differential activity
n the dorsal and ventral regions of the hippocampus during spa-
ial and anxiety components of a radial arm maze task (McHugh
t al., 2011). Further unpublished data from our lab shows that hip-
ocampal activity measured using CPEs and Pt/PPD/GOx biosensors Methods 215 (2013) 110– 120
can be used to compare different behaviours in a +-maze task. This
form of data acquisition during behavioural tasks can be coupled
with drug interventions and the changes observed can be compared
directly to more traditional methods such as electrophysiological
recordings and microdialysis sampling.
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